<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01631526</url>
  </required_header>
  <id_info>
    <org_study_id>REC12-053</org_study_id>
    <nct_id>NCT01631526</nct_id>
  </id_info>
  <brief_title>Vitamin D Loading Dose in Advanced Lung Cancer</brief_title>
  <official_title>Open Clinical Trial to Validate a Short-term Vitamin D Loading and Maintenance Dose Protocol in People With Advanced Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jewish General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jewish General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypovitaminosis D is highly prevalent in people with lung cancer, and may have adverse
      clinical consequences. The long and variable pharmacokinetic half-life of vitamin D makes
      prompt vitamin D replacement problematic. This is an open, one-armed therapeutic intervention
      using a loading dose of vitamin D that will be predicted to increase plasma 25-hydroxyvitamin
      D concentrations of every patient well into the normal range (&gt; 100 nmol/L) within 2 or 3
      weeks and monitored after 2 and 3 weeks of loading and maintenance dose. Preliminary data
      will also be obtained to identify potentially clinical important outcome benefits for future
      investigation. The outcomes are

        1. plasma 25OHD concentration

        2. Vitamin D binding protein and other plasma concentrations

        3. Mood and symptom
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma 25-hydroxyvitamin D concentration</measure>
    <time_frame>3 weeks</time_frame>
    <description>Plasma 25OHD concentration measured within 24 h prior to commencing vitamin D therapy, and again after 14 and 21 days of continuous vitamin D therapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mood</measure>
    <time_frame>3 weeks</time_frame>
    <description>Two validated brief mood assessment questionnaires measured
On two occasions (one week apart) at baseline prior to staring therapy
After 2 weeks of therapy
After 3 weeks of therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms</measure>
    <time_frame>3 weeks</time_frame>
    <description>As with mood questionnaire, a symptom questionnaire (Edmonton Symptom Assessment System) will be administered two times (one week apart) prior to starting vitamin therapy and after 14 and 21 days of continuous vitamin D administration</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>vitamin D 20,000 IU per day for 2 weeks followed by 10,000 IU per day for a further 7 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D</intervention_name>
    <description>vitamin D3 20,000 IU per day for 14 days followed by 10,000 IU per day for a further 7 days</description>
    <arm_group_label>Vitamin D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Any patient with advanced lung cancer whether or not receiving specific anti-cancer
             therapy

          2. Mentally competent (but need not be fluent in French or English if capable neutral
             translator available)

          3. Self report of reduced food intake and/or involuntary weight loss of any extent at
             time of enrollment: does not have to be documented

        Exclusion Criteria:

          1. Current diagnosis of primary hyperparathyroidism

          2. Nephrocalcinosis

          3. Current or suspected active tuberculosis, histoplasmosis, sarcoidosis, or other
             granulomatous disease

          4. Current using a vitamin D supplement providing &gt; 1000 IU/day

          5. Current prescribed calcitriol in any dose

          6. History of extensive sunlight exposure (&gt; 30 min summer sunlight exposure per day for
             more than 5 days per week) in previous 3 months

          7. Expected to die within next 2 months

          8. Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Brojde Lung Cancer Centre, Jewish General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2012</study_first_submitted>
  <study_first_submitted_qc>June 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2012</study_first_posted>
  <last_update_submitted>August 15, 2017</last_update_submitted>
  <last_update_submitted_qc>August 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jewish General Hospital</investigator_affiliation>
    <investigator_full_name>John Hoffer</investigator_full_name>
    <investigator_title>Professor of Medicine, McGill University</investigator_title>
  </responsible_party>
  <keyword>Lung cancer</keyword>
  <keyword>vitamin D</keyword>
  <keyword>pharmacokinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

